Triple
T33291875
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | quinidine |
E852339
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | antiarrhythmic agent |
C21589
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: antiarrhythmic agent Context triple: [quinidine, instanceOf, antiarrhythmic agent]
-
A.
anticoagulant drug
An anticoagulant drug is a medication that reduces the blood’s ability to clot, helping to prevent or treat conditions such as deep vein thrombosis, pulmonary embolism, and stroke.
-
B.
antiplatelet medication
An antiplatelet medication is a drug that inhibits platelet activation and aggregation to reduce the risk of blood clot formation and related cardiovascular events.
-
C.
potassium channel blocker
chosen
A potassium channel blocker is a substance that inhibits the flow of potassium ions through potassium channels in cell membranes, thereby altering cellular excitability and electrical signaling.
-
D.
oral anticoagulant
An oral anticoagulant is a medication taken by mouth that reduces the blood’s ability to clot, helping to prevent and treat conditions such as stroke, deep vein thrombosis, and pulmonary embolism.
-
E.
lipid-lowering agent
A lipid-lowering agent is a drug or substance used to reduce levels of fats (such as cholesterol and triglycerides) in the blood to prevent or treat cardiovascular disease.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f349660ff48190a4568803d0b89941 |
completed | April 30, 2026, 12:21 p.m. |
Created at: May 1, 2026, 1:32 a.m.